Doctors behaving badly?

Martin H N Tattersall and Ian H Kerridge
Med J Aust 2006; 185 (6): . || doi: 10.5694/j.1326-5377.2006.tb00579.x
Published online: 18 September 2006

It is in doctors’ and the drug industry’s best interests that their interactions be openly declared

There is no such thing as a free lunch. Pharmaceutical companies lavish meals, five-star travel, cash and gifts on doctors for one reason: to encourage them to prescribe their drugs. The standard retort from the medical profession is that doctors have sufficient clinical objectivity — and personal integrity — not to be so crudely swayed. Perhaps so.1

  • 1 Department of Cancer Medicine, University of Sydney, Sydney, NSW.
  • 2 Centre for Values, Ethics and the Law in Medicine, University of Sydney, Sydney, NSW.


Competing interests:

None identified.

  • 1. Stop the gravy train [editorial]. Sydney Morning Herald 2006; 7 Aug: 8.
  • 2. Moynihan R. The sugar-coated pill. The Australian 2006; 25 July: 10.
  • 3. Wanzana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA 2000; 283: 373-380.
  • 4. Kassirer JP. On the take. How medicine’s complicity with big business can endanger your health. Oxford: Oxford University Press, 2005.
  • 5. Moynihan R. Doctor treats to be disclosed. The Australian 2006; 26 Jul.
  • 6. Rogers C. The necessary and sufficient conditions of therapeutic personality change. J Consult Psychol 1957; 21: 95-103.
  • 7. Giddens A. The consequences of modernity. Cambridge: Polity Press, 1990.
  • 8. Baier A. Trust and antitrust. In: Moral prejudices: essays on ethics. Cambridge, Mass: Harvard University Press, 1955.
  • 9. O’Neill O. Autonomy and trust in bioethics. Cambridge: Cambridge University Press, 2002.
  • 10. Little JM. Community, security and human flourishing: an exploratory essay. Sydney: Centre for Values, Ethics and the Law in Medicine, 2004.
  • 11. Gilson L. Trust and the development of health care as a social institution. Soc Sci Med 2003; 56: 1453-1468.
  • 12. Thompson D. Understanding financial conflicts of interest. N Engl J Med 1993; 329: 573-576.
  • 13. Pearson SD, Kleinman K, Rusinak D, Levinson W. A trial of disclosing physicians’ financial incentives to patients. Arch Intern Med 2006; 166: 623-628.
  • 14. Breen KJ. The medical profession and the pharmaceutical industry: when will we open our eyes? Med J Aust 2004; 180: 409-410. <MJA full text>
  • 15. Tattersall M, Kerridge I. The drug industry and medical professionalism. Lancet 2006; 367: 28.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.